[Experiences with cytostatic combination therapy in hormone-resistant metastasizing breast cancer].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001792:Blood Platelets / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D007962:Leukocytes / Q000187:drug effects; D008727:Methotrexate / Q000627:therapeutic use; D009362:Neoplasm Metastasis / Q000188:drug therapy*
D000970:Antineoplastic Agents; D006728:Hormones; D002699:Chlorambucil; D003520:Cyclophosphamide; D008727:Methotrexate
Erfahrungen mit einer zytostatischen Kombinationstherapie beim hormonresistenten metastasierenden Mammakarzinom.